PatientsVille.com Logo

PatientsVille

Tanatril Side Effects

Common Tanatril Side Effects


The most commonly reported Tanatril side effects (click to view or check a box to report):

Blood Creatinine Increased (5)
Maternal Exposure During Pregnancy (4)
Oligohydramnios (3)
Hypertensive Nephropathy (3)
Renal Impairment (3)
Polyhydramnios (3)
Threatened Labour (3)
Cerebral Infarction (2)
Congenital Cystic Kidney Disease (2)
Diabetes Mellitus (2)
Urinary Tract Infection (2)
Kidney Enlargement (2)
Urinary Retention (2)
Amniotic Fluid Volume Decreased (2)
Atrioventricular Block Complete (1)
Urine Output Decreased (1)
Apnoeic Attack (1)
Activated Partial Thromboplastin Time Prolonged (1)
Delirium (1)
Acute Myocardial Infarction (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Tanatril Side Effects Reported to FDA

The following Tanatril reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Tanatril on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Convulsion
This is a report of a male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Tanatril (dosage: 5 Mg, start time: Mar 06, 2012), combined with:
  • Rivastach (18 Mg)
  • Maglax (330 Mg)
  • Pradaxa (220 Mg)
  • Mucosta (100 Mg)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Convulsion
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tanatril treatment in male patients, resulting in convulsion side effect.

Haemorrhage Subcutaneous, Renal Impairment, International Normalised Ratio Increased, Benign Prostatic Hyperplasia, Activated Partial Thromboplastin Time Prolonged, Dysuria
This report suggests a potential Tanatril Haemorrhage Subcutaneous, Renal Impairment, International Normalised Ratio Increased, Benign Prostatic Hyperplasia, Activated Partial Thromboplastin Time Prolonged, Dysuria side effect(s) that can have serious consequences. A male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Tanatril (dosage: 5 Mg) starting NS. Soon after starting Tanatril the patient began experiencing various side effects, including:
  • Haemorrhage Subcutaneous
  • Renal Impairment
  • International Normalised Ratio Increased
  • Benign Prostatic Hyperplasia
  • Activated Partial Thromboplastin Time Prolonged
  • Dysuria
Drugs used concurrently:
  • Pradaxa (220 Mg)
  • Anplag (300 Mg)
  • Equa (50 Mg)
  • Carvedilol (2.5 Mg)
  • Slow-k (1800 Mg)
  • Rezaltas
  • Alinamin-f (50 Mg)
  • Aspirin (100 Mg)
The patient was hospitalized. Although Tanatril demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as haemorrhage subcutaneous, may still occur.

Dizziness, Delirium, Loss Of Consciousness
This Dizziness, Delirium, Loss Of Consciousness problem was reported by a physician from JAPAN. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension. On Apr 01, 2011 this consumer started treatment with Tanatril (dosage: 10 Mg). The following drugs were being taken at the same time:
  • Micardis (40 Mg)
  • Neo-minophagen C
  • Livact (12.45 Mg)
  • Amaryl (1 Mg)
  • Doxazosin Mesylate (1 Mg)
When commencing Tanatril, the patient experienced the following unwanted symptoms/side effects:
  • Dizziness
  • Delirium
  • Loss Of Consciousness
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as dizziness, may become evident only after a product is in use by the general population.

Renal Impairment
This is a report of a 87-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Tanatril ^algol^ (dosage: 5 Mg/day) starting Nov 12, 2011. Concurrently used drugs:
  • Kremezin (6 Df/day)
  • Amlodipine (10 Mg/day)
  • Telmisartan And Hydrochlorothiazide (1 Df/day)
  • Prodec (100 Mg/day)
Soon after that, the consumer experienced the following side effects:
  • Renal Impairment
The patient was hospitalized. This opens a possibility that Tanatril ^algol^ treatment could cause the above reactions, including renal impairment, and some male subjects may be more susceptible.


Urinary Retention, Urinary Tract Infection
A 73-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Tanatril ^tanabe^ treatment (dosage: 2.5 Mg, 1x/day) on Aug 27, 2011. Soon after starting Tanatril ^tanabe^ treatment, the subject experienced various side effects, including:
  • Urinary Retention
  • Urinary Tract Infection
Concurrently used drugs:
  • Voglibose (0.3 Mg, 3x/day)
  • Promacta (75 Mg, 2x/day)
  • Pregabalin (75 Mg, 2x/day)
  • Pregabalin (75 Mg, 1x/day)
  • Lasix (40 Mg, 1x/day)
  • Lac B (1 G, 3x/day)
  • Bisolvon (4 Mg, 3x/day)
  • Allegra (60 Mg, 2x/day)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Tanatril ^tanabe^.

Urinary Retention, Urinary Tract Infection
A 73-year-old male patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Tanatril ^tanabe^(dosage: 2.5 Mg, 1x/day). The treatment was initiated on Aug 18, 2011. After that a consumer reported the following side effect(s):
  • Urinary Retention
  • Urinary Tract Infection
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Tanatril ^tanabe^ efficacy:
  • Voglibose (0.3 Mg, 3x/day)
  • Promac /jpn/ (75 Mg, 2x/day)
  • Pregabalin (75 Mg, 1x/day)
  • Lasix (40 Mg, 1x/day)
  • Lac B (1 G, 3x/day)
  • Bisolvon (4 Mg, 3x/day)
  • Allegra (60 Mg, 2x/day)
  • Magmitt (0.5 G, 2x/day)
The patient was hospitalized.

Polyhydramnios, Amniotic Fluid Volume Decreased, Hypertensive Nephropathy, Oligohydramnios, Threatened Labour, Pre-eclampsia, Maternal Exposure During Pregnancy
In this report, Tanatril was administered for the following condition: hypertension.A female consumer from JAPAN (weight: NA) started Tanatril treatment (dosage: 1 Df, Daily) on May 16, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Polyhydramnios
  • Amniotic Fluid Volume Decreased
  • Hypertensive Nephropathy
  • Oligohydramnios
  • Threatened Labour
  • Pre-eclampsia
  • Maternal Exposure During Pregnancy
A possible interaction with other drugs could have contributed to this reaction:
  • Atelec (Unk Ukn, Unk)
  • Diovan (Unk Ukn, Unk)
  • Aldomet
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Tanatril treatment could be related to the listed above side effect(s).

Kidney Enlargement, Congenital Cystic Kidney Disease, Renal Failure, Blood Creatinine Increased, Metabolic Acidosis, Foetal Exposure During Pregnancy, Apnoeic Attack, Premature Labour, Jaundice
This is a report of the following Tanatril side effect(s):
  • Kidney Enlargement
  • Congenital Cystic Kidney Disease
  • Renal Failure
  • Blood Creatinine Increased
  • Metabolic Acidosis
  • Foetal Exposure During Pregnancy
  • Apnoeic Attack
  • Premature Labour
  • Jaundice
A female patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Tanatril (dosage: Maternal Dose (1 Df Daily)) starting: May 16, 2011.The following concurrently used drugs could have generated interactions:
  • Atelec
  • Aldomet
  • Diovan (Maternal Dose)
The patient was hospitalized.This report suggests that a Tanatril treatment could be associated with the listed above side effect(s).

Rhabdomyolysis
This Tanatril report was submitted by a male consumer from JAPAN (weight: NA). The patient was diagnosed with: hypertension and Tanatril was administered (dosage: 2.5 Mg) starting: Jul 31, 2011. The consumer developed a set of symptoms:
  • Rhabdomyolysis
Other drugs used simultaneously:
  • Dogmatyl
  • Pradaxa (220 Mg)
  • Acecol
  • Vitaneurin
  • Betamac (100 Mg)
  • Isosorbide Dinitrate (40 Mg)
  • Alinamin-f (75 Mg)
  • Atelec (10 Mg)
The patient was hospitalized.Those unexpected symptoms could be linked to a Tanatril treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Purpura
This is a report of a possible correlation between Tanatril use and the following symptoms/side effect(s):
  • Purpura
which could contribute to an assessment of Tanatril risk profile.A female consumer from JAPAN (weight: NA) was suffering from NA and was treated with Tanatril (dosage: 2.5mg Per Day) starting Aug 04, 2011.Other concurrent medications:
  • Levothyroxine Sodium (50mcg Per Day)
  • Dezolam (1.5mg Per Day)
  • Lac B (3g Per Day)
  • Promacta (12.5mg Per Day)
  • Ozex (450mg Per Day)
The patient was hospitalized.

Kidney Enlargement, Congenital Cystic Kidney Disease, Renal Impairment, Renal Failure Neonatal, Blood Creatinine Increased, Maternal Exposure During Pregnancy
A female patient from JAPAN (weight: NA) presented with the following symptoms: NA and after a treatment with Tanatril (dosage: Unk Ukn, Unk) experienced the following side effect(s):
  • Kidney Enlargement
  • Congenital Cystic Kidney Disease
  • Renal Impairment
  • Renal Failure Neonatal
  • Blood Creatinine Increased
  • Maternal Exposure During Pregnancy
The treatment was started on May 16, 2011. Tanatril was used in combination with the following drugs:
  • Atelec
  • Diovan (Unk Ukn, Unk)
  • Aldomet
This report could alert potential Tanatril consumers.

Polyhydramnios, Threatened Labour, Oligohydramnios, Amniotic Fluid Volume Decreased, Hypertensive Nephropathy, Maternal Exposure During Pregnancy
In this report, a female patient from JAPAN (weight: NA) was affected by a possible Tanatril side effect.The patient was diagnosed with hypertension. After a treatment with Tanatril (dosage: NA, start date: May 16, 2011), the patient experienced the following side effect(s):
  • Polyhydramnios
  • Threatened Labour
  • Oligohydramnios
  • Amniotic Fluid Volume Decreased
  • Hypertensive Nephropathy
  • Maternal Exposure During Pregnancy
The following simultaneously used drugs could have led to this reaction:
  • Atelec
  • Diovan
  • Aldomet
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Tanatril treatment.

Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
This is a report of a 70-year-old female patient from JAPAN (weight: NA), who used Tanatril (dosage: NA) for a treatment of NA. After starting a treatment on May 31, 2011, the patient experienced the following side effect(s):
  • Hyponatraemia
  • Inappropriate Antidiuretic Hormone Secretion
The following drugs could possibly have interacted with the Tanatril treatment
  • Famotidine
  • Lendormin D
  • Pursennid /00571901/
  • Claritin
  • Peg-intron (80 Mcg;qw;sc)
  • Alprazolam
  • Amoban
  • Rebetol (600 Mg;qd;po)
The patient was hospitalized.Taken together, these observations suggest that a Tanatril treatment could be related to side effect(s), such as Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion.

Tuberculin Test Positive
This tuberculin test positive side effect was reported by a physician from GREECE. A 41-year-old male patient (weight:NA) experienced the following symptoms/conditions: hypertension,psoriasis. The patient was prescribed Tanatril (dosage: NA), which was started on Jan 01, 2010. Concurrently used drugs:
  • Remicade
  • Remicade
When starting to take Tanatril the consumer reported the following symptoms:
  • Tuberculin Test Positive
These side effects may potentially be related to Tanatril.

Threatened Labour, Polyhydramnios, Hypertensive Nephropathy, Maternal Exposure During Pregnancy, Oligohydramnios
This is a Tanatril side effect report of a female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: hypertension, who was treated with Tanatril (dosage:Unk Ukn, Unk, start time: May 16, 2011), combined with:
  • Atelec (Unk Ukn, Unk)
  • Diovan (Unk Ukn, Unk)
  • Aldomet (Unk Ukn, Unk)
, and developed a serious reaction and a threatened labour side effect. The patient presented with:
  • Threatened Labour
  • Polyhydramnios
  • Hypertensive Nephropathy
  • Maternal Exposure During Pregnancy
  • Oligohydramnios
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Tanatril treatment in female patients suffering from hypertension, resulting in threatened labour.

Blood Creatinine Increased
This report suggests a potential Tanatril blood creatinine increased side effect(s) that can have serious consequences. A 67-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): NA and used Tanatril (dosage: NA) starting Feb 10, 2011. Soon after starting Tanatril the patient began experiencing various side effects, including:
  • Blood Creatinine Increased
Drugs used concurrently:
  • Pletal
  • Methycobal
  • Calblock
  • Januvia
  • Amaryl
  • Urso 250
  • Candesartan Cilexetil
  • Actos
Although Tanatril demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as blood creatinine increased, may still occur.

Off Label Use, Blood Potassium Increased, Blood Creatine Phosphokinase Increased
This off label use problem was reported by a pharmacist from JAPAN. A 9-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On May 20, 2011 a consumer started treatment with Tanatril (dosage: NA). The following drugs/medications were being taken at the same time:
  • Calcium Carbonate
  • Kalimate
  • Cozaar
  • Cozaar
  • Kremezin
  • Sodium Bicarbonate
When commencing Tanatril, the patient experienced the following unwanted symptoms /side effects:
  • Off Label Use
  • Blood Potassium Increased
  • Blood Creatine Phosphokinase Increased
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as off label use, may become evident only after a product is in use by the general population.

Hypotension
This is a Tanatril (imidapril Hydrochloride)tablet side effect report of a 62-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Tanatril (imidapril Hydrochloride)tablet (dosage: Oral) starting Jan 14, 2011. Concurrently used drugs:
  • Samsca (Oral)
  • Samsca (Oral)
  • Fluitran (trichlormethiazide)tablet (Oral)
Soon after that, the consumer experienced the following of symptoms:
  • Hypotension
This opens a possibility that Tanatril (imidapril Hydrochloride)tablet could cause hypotension and that some male patients may be more susceptible.

Cerebral Infarction, Monoplegia
A 68-year-old male patient (weight: NA) from JAPAN with the following symptoms: hypertension started Tanatril treatment (dosage: 5mg, Daily) on May 14, 2011. Soon after starting Tanatril treatment, the consumer experienced several side effects, including:
  • Cerebral Infarction
  • Monoplegia
. Concurrently used drugs:
  • Almarl (Unk)
  • Omeprazole (20mg, Daily)
  • Adalat (40mg, Daily)
  • Adalat (20mg, Daily)
  • Trichlormethiazide (0.5mg, Daily)
  • Varenicline Tartrate (2mg, Daily)
This finding indicates that some patients can be more vulnerable to developing Tanatril side effects, such as cerebral infarction.

Road Traffic Accident
This road traffic accident side effect was reported by a health professional from JAPAN. A 52-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Tanatril (imidapril Hydrochloride) (dosage: NA), which was started on Jan 06, 2009. Concurrently used drugs:
  • Actos (15 Mg (15 Mg, 1 D), Per Oral)
  • Basen (voglibose)
  • Blopress (candesartan Cilexetil)
  • Amlodipine Besylate
  • Amaryl
.When starting to take Tanatril (imidapril Hydrochloride) the consumer reported symptoms, such as:
  • Road Traffic Accident
These side effects may potentially be related to Tanatril (imidapril Hydrochloride).

Hepatic Cirrhosis, Hepatitis B, Condition Aggravated
This is a report of a 75-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Tanatril (dosage: NA, start time: Oct 18, 2006), combined with:
  • Phenytoin (Po)
  • Norvasc
  • Temodal (75 Mg/m2;qd;po)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Hepatic Cirrhosis
  • Hepatitis B
  • Condition Aggravated
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tanatril treatment in male patients, resulting in hepatic cirrhosis side effect.

Cerebral Infarction
This report suggests a potential Tanatril Cerebral Infarction side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: hypertension,cerebrovascular accident prophylaxis and used Tanatril (dosage: 5 Mg) starting Apr 22, 2011. Soon after starting Tanatril the patient began experiencing various side effects, including:
  • Cerebral Infarction
Drugs used concurrently:
  • Pradaxa (300 Mg)
The patient was hospitalized. Although Tanatril demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cerebral infarction, may still occur.

Atrioventricular Block Complete
This Atrioventricular Block Complete problem was reported by a physician from JAPAN. A 75-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Tanatril (dosage: NA). The following drugs were being taken at the same time:
  • Selbex
  • Verapamil Hcl
  • Warfarin Sodium
  • Lyrica
  • Rhythmy
  • Aricept
  • Lasix
  • Loxonin
When commencing Tanatril, the patient experienced the following unwanted symptoms/side effects:
  • Atrioventricular Block Complete
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as atrioventricular block complete, may become evident only after a product is in use by the general population.

Cellulitis, Hypertriglyceridaemia, Pneumonia, Hypercholesterolaemia, Diabetes Mellitus
This is a report of a male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Tanatril (dosage: NA) starting Mar 04, 2011. Concurrently used drugs:
  • Zetia
  • Fastic
  • Seibule
  • Actemra
  • Lansoprazole
  • Allegra
  • Aurothiomalate
  • Actemra
Soon after that, the consumer experienced the following side effects:
  • Cellulitis
  • Hypertriglyceridaemia
  • Pneumonia
  • Hypercholesterolaemia
  • Diabetes Mellitus
The patient was hospitalized. This opens a possibility that Tanatril treatment could cause the above reactions, including cellulitis, and some male subjects may be more susceptible.

White Blood Cell Count Decreased, Neutropenia
A 73-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: myocardial infarction,insomnia started Tanatril treatment (dosage: 5 Mg, Daily) on Dec 10, 2010. Soon after starting Tanatril treatment, the subject experienced various side effects, including:
  • White Blood Cell Count Decreased
  • Neutropenia
Concurrently used drugs:
  • Amoban (7.5 Mg, Daily)
  • Frandol (40 Mg/day Qd)
  • Aspirin (100 Mg, Daily)
  • Lasix (20 Mg, 1x/day)
  • Lyrica (25 Mg/day)
  • Humalog (21 Lu/day)
  • Zosyn (2.25 G, 3x/day)
  • Plavix (75 Mg, 1x/day)
This finding indicates that some male patients could be more vulnerable to Tanatril.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Tanatril Side Effects

    Did You Have a Tanatril Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Tanatril for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Tanatril Safety Alerts, Active Ingredients, Usage Information

    More About Tanatril

    Side Effects reported to FDA: 27

    Tanatril safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 13

    Latest Tanatril clinical trials

    Tanatril Reviews

    No reviews, be a first to report a side effect via side effect reporting form